"advanced cancer" trang 4 - tải miễn phí từ tailieuXANH
Sunitinib in combination with trastuzumab for the treatment of advanced breast cancer: Activity and safety results from a phase II study

Sunitinib in combination with trastuzumab for the treatment of advanced breast cancer: Activity and safety results from a phase II study
10    63    0
Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy

Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy
5    51    0
Chemotherapy regimens for advanced pancreatic cancer: A systematic review and network meta-analysis

Chemotherapy regimens for advanced pancreatic cancer: A systematic review and network meta-analysis
13    51    0
VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: A comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: A comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
9    61    0
Neoadjuvant chemoradiotherapy for patients with unresectable radically locally advanced colon cancer: A potential improvement to overall survival and decrease to multivisceral resection

Neoadjuvant chemoradiotherapy for patients with unresectable radically locally advanced colon cancer: A potential improvement to overall survival and decrease to multivisceral resection
13    40    1
Palliative Gastrectomy versus Gastrojejunostomy for advanced Gastric cancer with outlet obstruction: A propensity score matching analysis

Palliative Gastrectomy versus Gastrojejunostomy for advanced Gastric cancer with outlet obstruction: A propensity score matching analysis
8    45    1
Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery

Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery
7    59    1
The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial

The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial
8    42    1
Addition of carboplatin-gemcitabine as second-line neoadjuvant chemotherapy in non-responsive locally advanced breast cancer patients to standard neoadjuvant chemotherapy and evaluation of factors affecting response: A randomized controlled trial

Addition of carboplatin-gemcitabine as second-line neoadjuvant chemotherapy in non-responsive locally advanced breast cancer patients to standard neoadjuvant chemotherapy and evaluation of factors affecting response: A randomized controlled trial
13    47    1
Beta-hydroxy beta-methylbutyrate/arginine/ glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: An open-label, multicentre, randomised, controlled phase II trial (NOURISH)

Beta-hydroxy beta-methylbutyrate/arginine/ glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: An open-label, multicentre, randomised, controlled phase II trial (NOURISH)
11    86    1
The correlation between skeletal muscle index of the L3 vertebral body and malnutrition in patients with advanced lung cancer

The correlation between skeletal muscle index of the L3 vertebral body and malnutrition in patients with advanced lung cancer
9    256    1
Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature

Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature
13    218    2
Eribulin improved the overall survival from the initiation of first-line chemotherapy for HER2-negative advanced breast cancer: A multicenter retrospective study

Eribulin improved the overall survival from the initiation of first-line chemotherapy for HER2-negative advanced breast cancer: A multicenter retrospective study
10    88    2
A network meta-analysis for efficacies and toxicities of different concurrent chemoradiotherapy regimens in the treatment of locally advanced non-small-cell lung cancer

A network meta-analysis for efficacies and toxicities of different concurrent chemoradiotherapy regimens in the treatment of locally advanced non-small-cell lung cancer
32    109    1
Assessment of preoperative axillary nodal disease burden: Breast MRI in locally advanced breast cancer before, during and after neoadjuvant endocrine therapy

Assessment of preoperative axillary nodal disease burden: Breast MRI in locally advanced breast cancer before, during and after neoadjuvant endocrine therapy
11    215    1
A predictive model for advanced oropharyngeal cancer patients treated with chemoradiation

A predictive model for advanced oropharyngeal cancer patients treated with chemoradiation
11    83    1
Short-course radiotherapy combined with CAPOX and Toripalimab for the total neoadjuvant therapy of locally advanced rectal cancer: A randomized, prospective, multicentre, double-arm, phase II trial (TORCH)

Short-course radiotherapy combined with CAPOX and Toripalimab for the total neoadjuvant therapy of locally advanced rectal cancer: A randomized, prospective, multicentre, double-arm, phase II trial (TORCH)
8    13    1
Predictive biomarkers for the efficacy of nivolumab as≥ 3rd-line therapy in patients with advanced gastric cancer: A subset analysis of ATTRACTION-2 phase III trial

Predictive biomarkers for the efficacy of nivolumab as≥ 3rd-line therapy in patients with advanced gastric cancer: A subset analysis of ATTRACTION-2 phase III trial
10    16    1
Identifying and handling unbalanced baseline characteristics in a non-randomized, controlled, multicenter social care nurse intervention study for patients in advanced stages of cancer

Identifying and handling unbalanced baseline characteristics in a non-randomized, controlled, multicenter social care nurse intervention study for patients in advanced stages of cancer
13    18    1
Massive digital gene expression analysis reveals different predictive profiles for immune checkpoint inhibitor therapy between adenocarcinoma and squamous cell carcinoma of advanced lung cancer

Massive digital gene expression analysis reveals different predictive profiles for immune checkpoint inhibitor therapy between adenocarcinoma and squamous cell carcinoma of advanced lung cancer
10    17    1
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.